PYXS Pyxis Oncology, Inc. - Common Stock
$3,38
Prix · Aoû 19, 2026
Données fondamentales au Aoû 13, 2026
Fourchette 52 semaines
$1–$6
52% of range
Note des analystes
STRONG BUY
15 analysts
Objectif de cours
$7
+114% upside
P/E (TTM)
-2.6
ROE
-112.9%
Marge nette
-574.5%
PYXS Aperçu de l'action Prix, capitalisation boursière, P/E, EPS, ROE, dette/capitaux propres, fourchette sur 52 semaines
Prix
$3.38
Capitalisation Boursière
$212M
P/E (TTM)
-2.6
BPA (TTM)
$-1.28
Revenus (TTM)
$14M
Rendement div.
—
ROE
-112.9%
Dette/Capitaux propres
—
Fourchette 52 semaines
$1 – $6
PYXS Graphique du cours de l'action OHLCV quotidien avec indicateurs techniques — panoramique, zoom et personnalisez votre vue
Configure
Performance sur 10 ans Tendances du chiffre d'affaires, du bénéfice net, des marges et du BPA
Revenus et bénéfice net
$14M
2024-12-31
→
2025-12-31
BPA
$-1.28
2021-12-31
→
2025-12-31
Flux de trésorerie libre
$-64M
2021-12-31
→
2025-12-31
Marges
-574.5%
Valorisation Ratios P/E, P/S, P/B, EV/EBITDA — l'action est-elle chère ou bon marché ?
Métrique
Tendance sur 5 ans
PYXS
Médiane des pairs
P/E (TTM)
-2.6
1.2
P/S (TTM)
15.3
18.5
P/B
4.0
1.6
Price / FCF (Cours / FCF)
-3.3
—
Rentabilité Marges brutes, d'exploitation et nettes ; ROE, ROA, ROIC
Métrique
Tendance sur 5 ans
PYXS
Médiane des pairs
Operating Margin (Marge d'exploitation)
-609.2%
—
Net Profit Margin (Marge nette)
-574.5%
-411.2%
ROA
-64.0%
-47.1%
ROE
-112.9%
-78.9%
ROIC
-160.9%
—
Santé financière Dette, liquidité, solvabilité — solidité du bilan
Métrique
Tendance sur 5 ans
PYXS
Médiane des pairs
Current Ratio (Ratio de liquidité)
3.4
6.6
Quick Ratio (Ratio de liquidité réduite)
3.2
—
Croissance Croissance du chiffre d'affaires, du BPA et du bénéfice net : Année/Année, TCAC 3 ans, TCAC 5 ans
Métrique
Tendance sur 5 ans
PYXS
Médiane des pairs
Revenue YoY (Chiffre d'affaires YoY)
-14.2%
—
Efficacité du capital Rotation des actifs, rotation des stocks, rotation des créances
Métrique
Tendance sur 5 ans
PYXS
Médiane des pairs
PYXS Consensus des analystes Opinions des analystes haussières et baissières, objectif de cours à 12 mois, potentiel de hausse
ACHAT
15 analystes
- Achat fort 7 46,7%
- Achat 6 40,0%
- Conserver 2 13,3%
- Vente 0 0,0%
- Vente forte 0 0,0%
Objectif de cours à 12 mois
9 analystes · 2026-08-16
Médiane
$7.00
← En dessous de tous les objectifs
$3.38
Bas
$5.00
Haut
$12.00
Objectif médian
$7.00
+107,1%
Objectif moyen
$7.22
+113,7%
Historique des bénéfices BPA réel vs estimation, surprise %, taux de succès, prochaine date de publication des résultats
Surprise Moyenne
0.03%
| Période | EPS Actual | BPA est. | Surprise |
|---|---|---|---|
| 31 mars 2026 | $-0.37 | $-0.38 | 0.01% |
| 31 décembre 2025 | $-0.29 | $-0.34 | 0.05% |
| 30 septembre 2025 | $-0.35 | $-0.35 | -0.00% |
| 30 juin 2025 | $-0.30 | $-0.36 | 0.06% |
| 31 mars 2025 | $-0.35 | $-0.30 | -0.05% |
| 31 décembre 2024 | $-0.25 | $-0.34 | 0.09% |
Comparaison des pairs (sous-secteur GICS) Indicateurs clés par rapport aux pairs du secteur
| Ticker | Capitalisation Boursière | P/E | Revenus Année/Année | Marge Nette | ROE | Marge Brute |
|---|---|---|---|---|---|---|
| PYXS | $72M | -0.9 | -14.2% | -574.5% | -112.9% | — |
| CNXU | — | — | — | — | — | — |
| GLSI | $300M | -14.7 | — | — | -2159.7% | — |
| RCEL | $105M | -2.0 | 11.5% | -67.8% | 328.9% | 82.1% |
| TARA | $286M | -4.0 | — | — | -33.7% | — |
| AKBA | $427M | -80.5 | 47.5% | -2.3% | -17.3% | — |
| ALEC | $172M | -1.1 | -79.1% | -679.2% | -280.7% | — |
| EBS | $644M | 13.3 | -28.8% | 7.1% | 9.9% | — |
Fondamentaux complets Tous les indicateurs par an — compte de résultat, bilan, flux de trésorerie
Compte de résultat 15
| Métrique | Tendance | 2025 | 2024 |
|---|---|---|---|
| Revenue | $14M | $16M | |
| Cost of Revenue | $2M | $475.0K | |
| R&D Expense | $74M | $59M | |
| SG&A Expense | $22M | $25M | |
| Operating Income | $-84M | $-89M | |
| Interest Income | $650.0K | $930.0K | |
| Other Non-op | $6M | $10M | |
| Pretax Income | $-78M | $-79M | |
| Income Tax | $1M | $-2M | |
| Net Income | $-80M | $-77M | |
| EPS (Basic) | $-1.28 | $-1.32 | |
| EPS (Diluted) | $-1.28 | $-1.32 | |
| Shares (Basic) | 62,143,166 | 58,445,765 | |
| Shares (Diluted) | 62,143,166 | 58,445,765 | |
| EBITDA | $-80M | $-86M |
Bilan 23
| Métrique | Tendance | 2025 | 2024 |
|---|---|---|---|
| Cash & Equivalents | $15M | $19M | |
| Short-term Investments | $51M | $107M | |
| Prepaid Expense | $4M | $4M | |
| Other Current Assets | $626.0K | $434.0K | |
| Current Assets | $72M | $132M | |
| PP&E (Net) | $8M | $10M | |
| PP&E (Gross) | $15M | $15M | |
| Accum. Depreciation | $7M | $5M | |
| Intangibles | $0 | $3M | |
| Total Assets | $92M | $157M | |
| Accounts Payable | $11M | $5M | |
| Accrued Liabilities | $9M | $11M | |
| Current Liabilities | $21M | $18M | |
| Capital Leases | $17M | $19M | |
| Deferred Tax | · | $0 | |
| Total Liabilities | $38M | $36M | |
| Common Stock | $63.0K | $60.0K | |
| Paid-in Capital | $496M | $484M | |
| Retained Earnings | $-443M | $-364M | |
| AOCI | $53.0K | $170.0K | |
| Stockholders' Equity | $53M | $121M | |
| Liabilities + Equity | $92M | $157M | |
| Shares Outstanding | 62,690,229 | 59,967,814 |
Flux de trésorerie 11
| Métrique | Tendance | 2025 | 2024 |
|---|---|---|---|
| D&A | $5M | $3M | |
| Stock-based Comp | $12M | $13M | |
| Deferred Tax | $0 | $-2M | |
| Other Non-cash | $-193.0K | $4M | |
| Operating Cash Flow | $-64M | $-58M | |
| CapEx | $9.0K | $237.0K | |
| Investing Cash Flow | $59M | $8M | |
| Financing Cash Flow | $594.0K | $59M | |
| Net Change in Cash | $-4M | $10M | |
| Taxes Paid | $1M | $164.0K | |
| Free Cash Flow | $-64M | $-58M |
Rentabilité 7
| Métrique | Tendance | 2025 | 2024 |
|---|---|---|---|
| Operating Margin | -609.2% | -554.1% | |
| Net Margin | -574.5% | -479.0% | |
| Pretax Margin | -564.6% | -492.3% | |
| EBITDA Margin | -576.6% | -535.6% | |
| ROA | -64.0% | -46.7% | |
| ROE | -112.9% | -56.4% | |
| ROIC | -160.9% | -72.1% |
Liquidité et Solvabilité 2
| Métrique | Tendance | 2025 | 2024 |
|---|---|---|---|
| Current Ratio | 3.4 | 7.5 | |
| Quick Ratio | 3.2 | 7.2 |
Efficacité 1
| Métrique | Tendance | 2025 | 2024 |
|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 |
Taux de croissance 1
| Métrique | Tendance | 2025 | 2024 |
|---|---|---|---|
| Revenue YoY | -14.2% | · |
Valorisation (TTM) 10
| Métrique | Tendance | 2025 | 2024 |
|---|---|---|---|
| Revenue TTM | $14M | $16M | |
| Net Income TTM | $-80M | $-77M | |
| Market Cap | $72M | $94M | |
| P/E | -0.9 | -1.2 | |
| P/S | 5.2 | 5.8 | |
| P/B | 1.3 | 0.8 | |
| P / Tangible Book | 1.3 | 0.8 | |
| P / Cash Flow | -1.1 | -1.6 | |
| P / FCF | -1.1 | -1.6 | |
| Earnings Yield | -111.3% | -84.6% |
Compte de résultat 16
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $11M | $0 | $3M | · | $0 | $0 | $0 | $16M | |
| Cost of Revenue | · | · | · | · | · | · | $0 | $0 | $0 | $475.0K | |
| R&D Expense | $16M | $20M | $22M | $18M | $17M | $17M | $14M | $18M | $14M | $13M | |
| SG&A Expense | $10M | $4M | $5M | $6M | $5M | $6M | $5M | $6M | $6M | $8M | |
| Operating Expenses | $26M | $24M | · | · | $23M | $23M | · | · | · | · | |
| Operating Income | $-26M | $-24M | $-18M | $-23M | $-20M | $-23M | $-40M | $-24M | $-20M | $-6M | |
| Interest Income | $61.0K | $218.0K | $225.0K | $242.0K | $99.0K | $84.0K | $87.0K | $194.0K | $387.0K | $262.0K | |
| Other Non-op | $644.0K | $1M | $1M | $1M | $2M | $2M | $2M | $3M | $3M | $2M | |
| Pretax Income | $-25M | · | $-17M | $-22M | $-18M | · | $-38M | $-21M | $-17M | · | |
| Income Tax | $0 | · | $1M | $0 | $283.0K | · | · | · | · | · | |
| Net Income | $-25M | $-23M | $-18M | $-22M | $-18M | $-21M | $-36M | $-21M | $-17M | $-3M | |
| EPS (Basic) | $-0.40 | $-0.37 | $-0.28 | $-0.35 | $-0.30 | $-0.35 | $-0.62 | $-0.35 | $-0.29 | $-0.06 | |
| EPS (Diluted) | $-0.40 | $-0.37 | $-0.28 | $-0.35 | $-0.30 | $-0.35 | $-0.62 | $-0.35 | $-0.29 | $-0.06 | |
| Shares (Basic) | 63,991,609 | 63,469,850 | -123,381,994 | 62,557,386 | 61,918,826 | 61,048,948 | -114,054,235 | 60,715,041 | 60,495,675 | 51,289,284 | |
| Shares (Diluted) | 63,991,609 | 63,469,850 | -123,381,994 | 62,557,386 | 61,918,826 | 61,048,948 | -114,054,235 | 60,715,041 | 60,495,675 | 51,289,284 | |
| EBITDA | $-26M | $-24M | · | $-23M | $-20M | $-22M | · | $-24M | $-20M | $-4M |
Bilan 24
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $19M | $6M | $15M | $9M | $11M | $13M | $19M | $12M | $25M | $28M | |
| Short-term Investments | $14M | $35M | $51M | $67M | $78M | $93M | $107M | $133M | $131M | $129M | |
| Receivables | · | · | · | · | $3M | · | · | · | · | $8M | |
| Prepaid Expense | $2M | $3M | $4M | $5M | $7M | $5M | $4M | $3M | $4M | $6M | |
| Other Current Assets | · | · | $626.0K | · | · | · | $434.0K | · | · | · | |
| Current Assets | $37M | $46M | $72M | $83M | $100M | $112M | $132M | $149M | $161M | $172M | |
| PP&E (Net) | $7M | $8M | $8M | $8M | $9M | $9M | $10M | $10M | $11M | $11M | |
| PP&E (Gross) | · | · | $15M | · | · | · | $15M | · | · | · | |
| Accum. Depreciation | · | · | $7M | · | · | · | $5M | · | · | · | |
| Intangibles | · | · | $0 | $2M | $2M | $3M | $3M | $24M | $24M | $24M | |
| Total Assets | $55M | $64M | $92M | $106M | $123M | $136M | $157M | $195M | $208M | $220M | |
| Accounts Payable | $3M | $5M | $11M | $10M | $9M | $3M | $5M | $5M | $5M | $2M | |
| Accrued Liabilities | $12M | $10M | $9M | $8M | $7M | $10M | $11M | $14M | $10M | $11M | |
| Current Liabilities | $27M | $17M | $21M | $19M | $18M | $14M | $18M | $20M | $17M | $14M | |
| Capital Leases | $16M | $16M | $17M | $17M | $18M | $18M | $19M | $19M | $19M | $20M | |
| Deferred Tax | · | · | · | · | · | · | · | $2M | $2M | $2M | |
| Total Liabilities | $43M | $33M | $38M | $37M | $36M | $33M | $36M | $42M | $39M | $36M | |
| Common Stock | $63.0K | $63.0K | $63.0K | $62.0K | $62.0K | $62.0K | $60.0K | $59.0K | $59.0K | $59.0K | |
| Paid-in Capital | $503M | $498M | $496M | $494M | $491M | $488M | $484M | $481M | $477M | $474M | |
| Retained Earnings | $-492M | $-466M | $-443M | $-425M | $-403M | $-385M | $-364M | $-328M | $-307M | $-289M | |
| AOCI | $-4.0K | $0 | $53.0K | $69.0K | $-5.0K | $49.0K | $170.0K | $351.0K | $-102.0K | $-60.0K | |
| Stockholders' Equity | $11M | $31M | $53M | $69M | $88M | $103M | $121M | $154M | $170M | $184M | |
| Liabilities + Equity | $55M | $64M | $92M | $106M | $123M | $136M | $157M | $195M | $208M | $220M | |
| Shares Outstanding | 63,434,936 | 62,831,246 | 62,690,229 | 62,149,664 | 62,018,135 | 61,631,376 | 59,967,814 | 59,449,998 | 58,914,712 | 58,803,126 |
Flux de trésorerie 9
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $301.0K | $459.0K | $3M | $527.0K | $535.0K | $552.0K | $550.0K | $731.0K | $585.0K | $1M | |
| Stock-based Comp | $6M | $1M | $2M | $3M | $3M | $4M | $3M | $3M | $3M | $4M | |
| Other Non-cash | · | $-4M | · | · | · | $-6M | · | · | · | $-23M | |
| Operating Cash Flow | $-18M | $-26M | $-10M | $-13M | $-17M | $-23M | $-19M | $-15M | $-3M | $-21M | |
| CapEx | · | · | $0 | · | · | · | $0 | $0 | $0 | $237.0K | |
| Investing Cash Flow | $21M | $16M | $16M | $11M | $15M | $16M | $27M | $-8.0K | $4.0K | $-18M | |
| Financing Cash Flow | $10M | $-25.0K | $669.0K | $-8.0K | $-67.0K | $0 | $50.0K | $2M | $110.0K | $58M | |
| Net Change in Cash | $13M | $-10M | $7M | $-2M | $-2M | $-7M | $7M | $-13M | $-3M | $18M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | $-21M |
Rentabilité 7
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | -700.4% | · | · | · | · | -34.7% | |
| Net Margin | · | · | · | · | -650.9% | · | · | · | · | -20.2% | |
| Pretax Margin | · | · | · | · | -640.8% | · | · | · | · | · | |
| EBITDA Margin | · | · | · | · | -700.4% | · | · | · | · | -27.8% | |
| ROA | -28.5% | -23.2% | · | -14.6% | -11.1% | -11.9% | · | -11.1% | -9.0% | -1.6% | |
| ROE | -51.2% | -34.6% | · | -19.8% | -14.3% | -14.7% | · | -14.5% | -11.0% | -1.9% | |
| ROIC | -227.2% | · | · | · | -22.9% | · | · | · | · | · |
Liquidité et Solvabilité 2
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 2.8 | · | 4.3 | 5.7 | 7.8 | · | 7.3 | 9.5 | 12.2 | |
| Quick Ratio | 1.2 | 2.5 | · | 3.9 | 5.2 | 7.3 | · | 7.1 | 9.2 | 11.7 |
Efficacité 2
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | 0.0 | · | · | · | · | 0.1 | |
| Receivables Turnover | · | · | · | · | 1.9 | · | · | · | · | 4.0 |
Valorisation (TTM) 8
| Métrique | Tendance | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-89M | $-85M | · | $-83M | $-78M | $-63M | · | $-65M | $-60M | $-61M | |
| Market Cap | $191M | $92M | · | $138M | $68M | $60M | · | $218M | $195M | $251M | |
| P/E | -2.1 | -1.1 | · | -1.6 | -0.9 | -0.9 | · | -2.9 | -2.5 | -2.7 | |
| P/B | 16.7 | 2.9 | · | 2.0 | 0.8 | 0.6 | · | 1.4 | 1.1 | 1.4 | |
| P / Tangible Book | 16.7 | 2.9 | · | 2.1 | 0.8 | 0.6 | · | 1.7 | 1.3 | 1.6 | |
| P / Cash Flow | · | -3.5 | · | · | · | -2.7 | · | · | · | -12.1 | |
| P / FCF | · | · | · | · | · | · | · | · | · | -12.0 | |
| Earnings Yield | -47.2% | -93.8% | · | -60.8% | -117.3% | -107.1% | · | -34.3% | -39.9% | -36.9% |
États financiers Compte de résultat, bilan, flux de trésorerie — annuel, sur les 5 dernières années
Compte de résultat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Revenu | $14M | $16M | — | — | — |
| Marge d'exploitation % | -609.2% | -554.1% | — | — | — |
| Résultat net | $-80M | $-77M | $-74M | $-121M | $-76M |
| BPA dilué | $-1.28 | $-1.32 | $-1.85 | $-3.65 | $-8.95 |
Bilan
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ratio de liquidité | 3.4 | 7.5 | 4.8 | — | 14.9 |
| Ratio de liquidité réduite | 3.2 | 7.2 | 4.6 | — | 14.7 |
Flux de trésorerie
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flux de trésorerie libre | $-64M | $-58M | $-77M | — | $-36M |
Mes métriques Votre watchlist personnelle — lignes sélectionnées de Fondamentaux Complets
📊
Choisissez les indicateurs qui vous importent — cliquez sur le ➕ à côté de n'importe quelle ligne dans Fondamentaux Complets ci-dessus.
Votre sélection est enregistrée et vous suit sur tous les tickers.
Détenteurs institutionnels (13F) 89 déclarants · $93.5M total · Au 30 juin 2026
Institutions qui déclarent détenir cette action dans leur Formulaire SEC 13F trimestriel. Uniquement les positions longues ; un même déclarant peut apparaître deux fois pour des jambes d'options distinctes. Les jambes put/call compensatoires importantes reflètent généralement la tenue de marché ou un inventaire couvert, pas une conviction directionnelle.
Activité institutionnelle — Q2 2026 vs trimestre précédent
| Nouvelles positions | Positions clôturées | Augmenté | Diminué | Variation nette des actions |
|---|---|---|---|---|
| 16 (+4 vs T. préc.) | 9 (-2 vs T. préc.) | 22 (+10 vs T. préc.) | 24 (-11 vs T. préc.) | +8.7M |
Comparé à Q1 2026. Les dépôts de formulaire 13F de la SEC sont dus dans les 45 jours suivant la fin du trimestre, plus une courte période tampon pour les déposants tardifs — les trimestres encore dans cette fenêtre sont ignorés au profit de la paire la plus récente entièrement déclarée.
| Institution | Valeur | Actions | % de 13F suivies | Type |
|---|---|---|---|---|
| GordonMD Global Investments LP | $30 174 976 | 10 024 909 | 32,28% | Actions |
| Pfizer Inc | $16 487 769 | 5 952 263 | 17,64% | Actions |
| Laurion Capital Management LP | $14 751 673 | 4 900 888 | 15,78% | Actions |
| VANGUARD CAPITAL MANAGEMENT LLC | $6 248 751 | 2 075 997 | 6,68% | Actions |
| Atle Fund Management AB | $2 909 041 | 966 459 | 3,11% | Actions |
| Palo Alto Investors LP | $2 601 474 | 864 277 | 2,78% | Actions |
| RENAISSANCE TECHNOLOGIES LLC | $2 324 418 | 772 232 | 2,49% | Actions |
| Woodline Partners LP | $1 577 237 | 523 999 | 1,69% | Actions |
| GEODE CAPITAL MANAGEMENT, LLC | $1 438 803 | 477 598 | 1,54% | Actions |
| 683 Capital Management, LLC | $1 382 695 | 459 367 | 1,48% | Actions |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $1 290 104 | 428 606 | 1,38% | Actions |
| DIADEMA PARTNERS LP | $1 168 482 | 388 200 | 1,25% | Option d'achat |
| Longaeva Partners L.P. | $1 064 282 | 353 582 | 1,14% | Actions |
| Decheng Capital LLC | $983 698 | 326 810 | 1,05% | Actions |
| VANGUARD FIDUCIARY TRUST CO | $911 988 | 302 986 | 0,98% | Actions |
| STATE STREET CORP | $748 999 | 248 837 | 0,80% | Actions |
| MILLENNIUM MANAGEMENT LLC | $701 342 | 233 004 | 0,75% | Actions |
| JANE STREET GROUP, LLC | $534 594 | 177 606 | 0,57% | Actions |
| Bank of New York Mellon Corp | $384 233 | 127 652 | 0,41% | Actions |
| NORTHERN TRUST CORP | $373 117 | 123 959 | 0,40% | Actions |
| NewEdge Wealth, LLC | $349 178 | 116 006 | 0,37% | Actions |
| VANGUARD GROUP INC | $346 032 | 300 897 | 0,37% | Actions |
| XTX Topco Ltd | $333 926 | 110 939 | 0,36% | Actions |
| TWO SIGMA INVESTMENTS, LP | $252 723 | 83 961 | 0,27% | Actions |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $244 593 | 81 260 | 0,26% | Actions |
| BANK OF AMERICA CORP /DE/ | $242 197 | 80 464 | 0,26% | Actions |
| JANE STREET GROUP, LLC | $221 837 | 73 700 | 0,24% | Option d'achat |
| Cable Car Capital, LP | $185 434 | 61 606 | 0,20% | Actions |
| MYDA Advisors LLC | $150 500 | 50 000 | 0,16% | Actions |
| Qube Research & Technologies Ltd | $150 295 | 49 932 | 0,16% | Actions |
| UNIVERSITY OF CHICAGO | $146 680 | 48 731 | 0,16% | Actions |
| CITADEL ADVISORS LLC | $142 424 | 47 317 | 0,15% | Actions |
| Quadrature Capital Ltd | $141 672 | 47 067 | 0,15% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $139 062 | 46 200 | 0,15% | Option d'achat |
| GOLDMAN SACHS GROUP INC | $138 159 | 45 900 | 0,15% | Actions |
| Verdad Advisers, LP | $135 146 | 44 899 | 0,14% | Actions |
| LPL Financial LLC | $131 098 | 43 554 | 0,14% | Actions |
| COMMONWEALTH EQUITY SERVICES, LLC | $127 790 | 42 455 | 0,14% | Actions |
| J. Derek Lewis & Associates Inc. | $126 420 | 42 000 | 0,14% | Actions |
| CITIGROUP INC | $114 997 | 38 205 | 0,12% | Actions |
| SIMPLEX TRADING, LLC | $114 085 | 37 902 | 0,12% | Actions |
| Point72 Asset Management, L.P. | $111 647 | 37 092 | 0,12% | Actions |
| Walleye Capital LLC | $110 702 | 36 778 | 0,12% | Actions |
| Nuveen Asset Management, LLC | $95 378 | 61 140 | 0,10% | Actions |
| MARSHALL WACE, LLP | $89 613 | 29 772 | 0,10% | Actions |
| DIMENSIONAL FUND ADVISORS LP | $82 426 | 27 384 | 0,09% | Actions |
| MACKENZIE FINANCIAL CORP | $79 292 | 26 343 | 0,08% | Actions |
| Cetera Investment Advisers | $75 250 | 25 000 | 0,08% | Actions |
| Cubist Systematic Strategies, LLC | $73 395 | 33 061 | 0,08% | Actions |
| Graham Capital Management, L.P. | $68 351 | 22 708 | 0,07% | Actions |
| Vanguard Global Advisers, LLC | $63 938 | 21 242 | 0,07% | Actions |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $56 889 | 18 900 | 0,06% | Option de vente |
| OSAIC HOLDINGS, INC. | $53 339 | 17 721 | 0,06% | Actions |
| GROUP ONE TRADING LLC | $49 605 | 16 480 | 0,05% | Actions |
| CITADEL ADVISORS LLC | $44 247 | 14 700 | 0,05% | Option d'achat |
| Point72 Asia (Singapore) Pte. Ltd. | $40 087 | 18 057 | 0,04% | Actions |
| FMR LLC | $35 801 | 11 894 | 0,04% | Actions |
| PACES FERRY WEALTH ADVISORS, LLC | $34 434 | 11 440 | 0,04% | Actions |
| BlackRock, Inc. | $33 941 | 11 276 | 0,04% | Actions |
| NewEdge Advisors, LLC | $30 853 | 10 250 | 0,03% | Actions |
| China Universal Asset Management Co., Ltd. | $30 350 | 10 083 | 0,03% | Actions |
| Tower Research Capital LLC (TRC) | $28 288 | 9 398 | 0,03% | Actions |
| MERCER GLOBAL ADVISORS INC /ADV | $27 542 | 9 150 | 0,03% | Actions |
| TWO SIGMA ADVISERS, LP | $26 018 | 22 624 | 0,03% | Actions |
| PNC Financial Services Group, Inc. | $19 565 | 6 500 | 0,02% | Actions |
| Persistent Asset Partners Ltd | $16 796 | 224 | 0,02% | Option d'achat |
| JPMORGAN CHASE & CO | $15 081 | 5 273 | 0,02% | Actions |
| HAGER INVESTMENT MANAGEMENT SERVICES, LLC | $15 050 | 5 000 | 0,02% | Actions |
| Federation des caisses Desjardins du Quebec | $13 545 | 4 500 | 0,01% | Actions |
| BARCLAYS PLC | $12 314 | 4 091 | 0,01% | Actions |
| FEDERATED HERMES, INC. | $8 916 | 2 962 | 0,01% | Actions |
| Mirae Asset Global Investments Co., Ltd. | $8 527 | 2 833 | 0,01% | Actions |
| UBS Group AG | $8 428 | 2 800 | 0,01% | Actions |
| BNP PARIBAS FINANCIAL MARKETS | $8 094 | 2 689 | 0,01% | Actions |
| FIRST UNITED BANK & TRUST | $7 375 | 2 500 | 0,01% | Actions |
| GF FUND MANAGEMENT CO. LTD. | $3 690 | 1 226 | 0,00% | Actions |
| NISA INVESTMENT ADVISORS, LLC | $2 893 | 961 | 0,00% | Actions |
| Physician Wealth Advisors, Inc. | $2 839 | 943 | 0,00% | Actions |
| SBI Securities Co., Ltd. | $1 532 | 509 | 0,00% | Actions |
| JONES FINANCIAL COMPANIES LLLP | $1 385 | 500 | 0,00% | Actions |
| MORGAN STANLEY | $1 054 | 350 | 0,00% | Actions |
| WELLS FARGO & COMPANY/MN | $858 | 285 | 0,00% | Actions |
| STIFEL FINANCIAL CORP | $713 | 237 | 0,00% | Actions |
| Cornerstone Financial Management LLC | $518 | 172 | 0,00% | Actions |
| ACADIAN ASSET MANAGEMENT LLC | $380 | 126 793 | 0,00% | Actions |
| Caitong International Asset Management Co., Ltd | $105 | 35 | 0,00% | Actions |
| CWM, LLC | $50 | 34 | 0,00% | Actions |
| Arax Advisory Partners | $42 | 14 | 0,00% | Actions |
| Winthrop Capital Management, LLC | $9 | 6 000 | 0,00% | Actions |
Initiés de la société 16 initiés · 7 dirigeants · 8 administrateurs
| Dirigeant | Rôle | Dernière activité | Actions détenues | Achats 12m | Ventes 12m | Net 12m |
|---|---|---|---|---|---|---|
| Lara Sullivan, M.D. | President ,CEO & CMO | 31 mars 2025 A | 2 403 882 | 0 | 0 | $0 |
| Connealy Pamela Yanchik | CFO & COO | 31 mars 2025 A | 1 199 143 | 0 | 0 | $0 |
| Ritu Shah | Chief Operating Officer | 7 octobre 2021 A | — | 0 | 0 | $0 |
| Jitendra Wadhane | Prin Fin & Acct Officer | 24 mars 2026 A | 512 882 | 0 | 0 | $0 |
| Ken Kobayashi | Chief Medical Officer | 29 décembre 2023 A | — | 0 | 0 | $0 |
| Jay Feingold | Chief Medical Officer | 24 mars 2023 A | 730 345 | 0 | 0 | $0 |
| Ronald Herbst | Chief Scientific Officer | 7 octobre 2021 A | — | 0 | 0 | $0 |
| Jakob Dupont | Administrateur | 30 juin 2026 M | 38 741 | 0 | 1 | $-107 100 |
| Santhosh Palani | Administrateur | 24 mars 2026 A | 6 000 | 0 | 0 | $0 |
| Darren S Cline | Administrateur | 24 mars 2026 A | 251 405 | 0 | 0 | $0 |
| Rachel Humphrey | Administrateur | 24 mars 2026 A | 81 309 | 0 | 3 | $-15 865 |
| Michael A Metzger | Administrateur | 24 mars 2026 A | — | 0 | 0 | $0 |
| Freda C Lewis-Hall | Administrateur | 24 mars 2026 A | 241 405 | 0 | 0 | $0 |
| John L Flavin | Administrateur | 24 mars 2026 A | 413 015 | 0 | 0 | $0 |
| Thomas Civik | — | 12 août 2026 A | 206 186 | 0 | 0 | $0 |
| Mark Chin | — | 21 avril 2022 S | 0 | 0 | 0 | $0 |
Initiés issus des déclarations SEC Form 3/4/5 ; net = uniquement P/S de marché
Activistes et détenteurs de 5%+ 2 participations
Investisseurs ayant déposé un Schedule 13D auprès de la SEC — détention effective supérieure à 5% avec l'intention d'influencer l'émetteur (participations activistes, campagnes pour le conseil d'administration, fusions-acquisitions). Chaque ligne montre le dernier état connu de la position du déposant.
| Déclarant | Déposé | Participation | Statut | Objectif | Dépôt |
|---|---|---|---|---|---|
| Lara Sullivan, M.D. ×2 dépôts | 2 avril 2025 | 11,21% | Amendement | — | SEC |
| Lara Sullivan ×4 dépôts | 3 avril 2024 | — | Dépôt initial | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Détention d'ETF Détenu par 6 ETFs
Le poids reflète uniquement les participations directes en actions (N-PORT) ; les fonds à effet de levier ou basés sur des dérivés peuvent détenir une exposition supplémentaire aux swaps non indiquée.
| Fonds | Poids | Unités | Au | Source |
|---|---|---|---|---|
| IWC · iShares Trust | 0,04% | 166 564 SH | 8 août 2026 | Quotidien |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,02% | 3 408 SH | 8 août 2026 | Quotidien |
| IBB · iShares Trust | 0,02% | 387 224 SH | 8 août 2026 | Quotidien |
| BIB · ProShares Trust | 0,01% | 2 303 NS | 31 mai 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 600 185 SH | 8 août 2026 | Quotidien |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 1 422 296 SH | 8 août 2026 | Quotidien |